Skip to main content
NCBI home page
Canadian Medical Association Journal logoLink to Canadian Medical Association Journal
. 1977 Aug 6;117(3):255-256, 259-262.

Myocardial infarction size: measurement and modification

John A Cairns
PMCID: PMC1879658  PMID: 69481

Abstract

The majority of in-hospital deaths from acute myocardial infarction occur as a result of the “power failure” syndrome (severe congestive heart failure and cardiogenic shock), which results from extensive loss of myocardium. The death of myocardial cells is sequential over many hours. Surrounding the central zone of necrosis in an acute myocardial infarction is a zone of ischemic myocardium whose fate might be altered by interventions during the early phase of the infarction. ST-segment mapping, serial measurement of the serum concentration of creatine phosphokinase and myocardial imaging by means of radionuclides are being developed for the noninvasive assessment of infarct size in animals and humans. A number of interventions appear to limit infarct size in animals. There have been relatively few studies in humans to date, but preliminary results suggest that infarct size might be limited by certain interventions. The research has provided important practical benefits in terms of understanding the course of acute myocardial infarction and the potential effects of conventional therapies. For the present, interventions designed to limit infarct size remain in the realm of clinical research; routine clinical use would be inappropriate.

Full text

PDF
255

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. An ethical consideration of large-scale clinical trials in cardiovascular diseases. Report of the Committee on Ethics of the American Heart Association. Circulation. 1975 Sep;52(3):5–9. doi: 10.1161/01.cir.52.3.5. [DOI] [PubMed] [Google Scholar]
  2. Braunwald E. Control of myocardial oxygen consumption: physiologic and clinical considerations. Am J Cardiol. 1971 Apr;27(4):416–432. doi: 10.1016/0002-9149(71)90439-5. [DOI] [PubMed] [Google Scholar]
  3. Braunwald E., Maroko P. R. The reduction of infarct size--an idea whose time (for testing) has come. Circulation. 1974 Aug;50(2):206–209. doi: 10.1161/01.cir.50.2.206. [DOI] [PubMed] [Google Scholar]
  4. Cox J. L., McLaughlin V. W., Flowers N. C., Horan L. G. The ischemic zone surrounding acute myocardial infarction. Its morphology as detected by dehydrogenase staining. Am Heart J. 1968 Nov;76(5):650–659. doi: 10.1016/0002-8703(68)90164-6. [DOI] [PubMed] [Google Scholar]
  5. DeMaria A. N., King J. F., Bogren H. G., Lies J. E., Mason D. T. The variable spectrum of echocardiographic manifestations of the mitral valve prolapse syndrome. Circulation. 1974 Jul;50(1):33–41. doi: 10.1161/01.cir.50.1.33. [DOI] [PubMed] [Google Scholar]
  6. Goldstein S. Letter: Pacing the WPW patient. Circulation. 1976 Jan;53(1):204–205. doi: 10.1161/01.cir.53.1.204. [DOI] [PubMed] [Google Scholar]
  7. Harnarayan C., Bennett M. A., Pentecost B. L., Brewer D. B. Quantitative study of infarcted myocardium in cardiogenic shock. Br Heart J. 1970 Nov;32(6):728–732. doi: 10.1136/hrt.32.6.728. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. JENNINGS R. B., BAUM J. H., HERDSON P. B. FINE STRUCTURAL CHANGES IN MYOCARDIAL ISCHEMIC INJURY. Arch Pathol. 1965 Feb;79:135–143. [PubMed] [Google Scholar]
  9. Kibe O., Nilsson N. J. Observations on the diagnostic and prognostic value of some enzyme tests in myocardial infarction. Acta Med Scand. 1967 Nov;182(5):597–610. doi: 10.1111/j.0954-6820.1967.tb10886.x. [DOI] [PubMed] [Google Scholar]
  10. Kjekshus J. K., Sobel B. E. Depressed myocardial creatine phosphokinase activity following experimental myocardial infarction in rabbit. Circ Res. 1970 Sep;27(3):403–414. doi: 10.1161/01.res.27.3.403. [DOI] [PubMed] [Google Scholar]
  11. Kluge W. F. Prognostic value of serum creatine phosphokinase levels in myocardial infarction. Northwest Med. 1969 Sep;68(9):847–853. [PubMed] [Google Scholar]
  12. Madias J. E., Madias N. E., Hood W. B., Jr Precordial ST-segment mapping. 2. Effects of oxygen inhalation on ischemic injury in patients with acute myocardial infarction. Circulation. 1976 Mar;53(3):411–417. doi: 10.1161/01.cir.53.3.411. [DOI] [PubMed] [Google Scholar]
  13. Maroko P. R., Braunwald E. Modification of myocardial infarction size after coronary occlusion. Ann Intern Med. 1973 Nov;79(5):720–733. doi: 10.7326/0003-4819-79-5-720. [DOI] [PubMed] [Google Scholar]
  14. Maroko P. R., Davidson D. M., Libby P., Hagan A. D., Braunwald E. Effects of hyaluronidase administration on myocardial ischemic injury in acute infarction. A preliminary study in 24 patients. Ann Intern Med. 1975 Apr;82(4):516–520. doi: 10.7326/0003-4819-82-4-516. [DOI] [PubMed] [Google Scholar]
  15. Maroko P. R., Kjekshus J. K., Sobel B. E., Watanabe T., Covell J. W., Ross J., Jr, Braunwald E. Factors influencing infarct size following experimental coronary artery occlusions. Circulation. 1971 Jan;43(1):67–82. doi: 10.1161/01.cir.43.1.67. [DOI] [PubMed] [Google Scholar]
  16. Maroko P. R., Libby P., Covell J. W., Sobel B. E., Ross J., Jr, Braunwald E. Precordial S-T segment elevation mapping: an atraumatic method for assessing alterations in the extent of myocardial ischemic injury. The effects of pharmacologic and hemodynamic interventions. Am J Cardiol. 1972 Feb;29(2):223–230. doi: 10.1016/0002-9149(72)90633-9. [DOI] [PubMed] [Google Scholar]
  17. Maroko P. R., Libby P., Sobel B. E., Bloor C. M., Sybers H. D., Shell W. E., Covell J. W., Braunwald E. Effect of glucose-insulin-potassium infusion on myocardial infarction following experimental coronary artery occlusion. Circulation. 1972 Jun;45(6):1160–1175. doi: 10.1161/01.cir.45.6.1160. [DOI] [PubMed] [Google Scholar]
  18. Muller J. E., Maroko P. R., Braunwald E. Evaluation of precordial electrocardiographic mapping as a means of assessing changes in myocardial ischemic injury. Circulation. 1975 Jul;52(1):16–27. doi: 10.1161/01.cir.52.1.16. [DOI] [PubMed] [Google Scholar]
  19. Page D. L., Caulfield J. B., Kastor J. A., DeSanctis R. W., Sanders C. A. Myocardial changes associated with cardiogenic shock. N Engl J Med. 1971 Jul 15;285(3):133–137. doi: 10.1056/NEJM197107152850301. [DOI] [PubMed] [Google Scholar]
  20. Pelides L. J., Reid D. S., Thomas M., Shillingford J. P. Inhibition by -blockade of the ST segment elevation after acute myocardial infarction in man. Cardiovasc Res. 1972 May;6(3):295–301. doi: 10.1093/cvr/6.3.295. [DOI] [PubMed] [Google Scholar]
  21. Roberts R., Henry P. D., Sobel B. E. An improved basis for enzymatic estimation of infarct size. Circulation. 1975 Nov;52(5):743–754. doi: 10.1161/01.cir.52.5.743. [DOI] [PubMed] [Google Scholar]
  22. Roe C. R., Starmer C. F. A sensitivity analysis of enzymatic estimation of infarct size. Circulation. 1975 Jul;52(1):1–5. doi: 10.1161/01.cir.52.1.1. [DOI] [PubMed] [Google Scholar]
  23. Shell W. E., Kjekshus J. K., Sobel B. E. Quantitative assessment of the extent of myocardial infarction in the conscious dog by means of analysis of serial changes in serum creatine phosphokinase activity. J Clin Invest. 1971 Dec;50(12):2614–2625. doi: 10.1172/JCI106762. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Shell W. E., Lavelle J. F., Covell J. W., Sobel B. E. Early estimation of myocardial damage in conscious dogs and patients with evolving acute myocardial infarction. J Clin Invest. 1973 Oct;52(10):2579–2590. doi: 10.1172/JCI107450. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Sobel B. E., Bresnahan G. F., Shell W. E., Yoder R. D. Estimation of infarct size in man and its relation to prognosis. Circulation. 1972 Oct;46(4):640–648. doi: 10.1161/01.cir.46.4.640. [DOI] [PubMed] [Google Scholar]
  26. Strauss H. W., Harrison K., Langan J. K., Lebowitz E., Pitt B. Thallium-201 for myocardial imaging. Relation of thallium-201 to regional myocardial perfusion. Circulation. 1975 Apr;51(4):641–645. doi: 10.1161/01.cir.51.4.641. [DOI] [PubMed] [Google Scholar]
  27. Swan H. J., Forrester J. S., Danzig R., Allen H. N. Power failure in acute myocardial infarction. Prog Cardiovasc Dis. 1970 May;12(6):568–600. doi: 10.1016/0033-0620(70)90022-8. [DOI] [PubMed] [Google Scholar]
  28. Zaret B., DiCola V. C., Donabedian R. K., Puri S., Wolfson S., Freedman G. S., Cohen L. S. Dual radionuclide study of myocardial infarction. Relationships between myocardial uptake of potassium-43, technetium-99m stannous pyrophosphate, regional myocardial blood flow and creatine phosphokinase depletion. Circulation. 1976 Mar;53(3):422–428. doi: 10.1161/01.cir.53.3.422. [DOI] [PubMed] [Google Scholar]

Articles from Canadian Medical Association Journal are provided here courtesy of Canadian Medical Association

RESOURCES